Frontotemporal Dementia and Pharmacologic Interventions
Overview
Psychiatry
Affiliations
Frontotemporal lobar degeneration is comprised of three syndromes: frontotemporal dementia (FTD), semantic dementia, and progressive nonfluent aphasia, with FTD being the most prevalent. FTD is characterized predominantly by character change and disordered social conduct. A variety of pathologies may underlie these syndromes, yet it is the location of the pathology rather than the type that dictates the clinical features of the disease. Several medications have been investigated to measure efficacy of treatment in FTD, often with mixed results. The authors review these findings and comment on future directions.
Primary progressive aphasia: six questions in search of an answer.
Belder C, Marshall C, Jiang J, Mazzeo S, Chokesuwattanaskul A, Rohrer J J Neurol. 2023; 271(2):1028-1046.
PMID: 37906327 PMC: 10827918. DOI: 10.1007/s00415-023-12030-4.
New Approaches to the Treatment of Frontotemporal Dementia.
Neylan K, Miller B Neurotherapeutics. 2023; 20(4):1055-1065.
PMID: 37157041 PMC: 10457270. DOI: 10.1007/s13311-023-01380-6.
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance.
Costello H, Roiser J, Howard R Psychol Med. 2023; 53(3):654-667.
PMID: 36621964 PMC: 9976038. DOI: 10.1017/S003329172200397X.
Primary progressive aphasia: a clinical approach.
Marshall C, Hardy C, Volkmer A, Russell L, Bond R, Fletcher P J Neurol. 2018; 265(6):1474-1490.
PMID: 29392464 PMC: 5990560. DOI: 10.1007/s00415-018-8762-6.
Li P, Quan W, Zhou Y, Wang Y, Zhang H, Liu S Exp Ther Med. 2016; 12(1):492-498.
PMID: 27347084 PMC: 4906973. DOI: 10.3892/etm.2016.3284.